Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention
NCT01470352
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
179
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Doluxetine
DRUG:
Placebo
Sponsor
d_yarnitsky